171 related articles for article (PubMed ID: 17168907)
1. Fibronectin gene expression differs in normal and abnormal human wound healing.
Sible JC; Eriksson E; Smith SP; Smith N
Wound Repair Regen; 1994 Jan; 2(1):3-19. PubMed ID: 17168907
[TBL] [Abstract][Full Text] [Related]
2. Gene expression of tenascin is altered in normal scars and keloids.
Sible JC; Rettig WJ; Eriksson E; Smith SP; Oliver N
Wound Repair Regen; 1995; 3(1):37-48. PubMed ID: 17168861
[TBL] [Abstract][Full Text] [Related]
3. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
4. Expression of fibronectin messenger RNA in hypertrophic and normal dermal tissues and in vitro regulation by interferon alfa-2b.
Ghahary A; Shen YJ; Scott PG; Tredget EE
Wound Repair Regen; 1993 Jul; 1(3):166-74. PubMed ID: 17163885
[TBL] [Abstract][Full Text] [Related]
5. Regulation of collagen gene expression in keloids and hypertrophic scars.
Friedman DW; Boyd CD; Mackenzie JW; Norton P; Olson RM; Deak SB
J Surg Res; 1993 Aug; 55(2):214-22. PubMed ID: 8412102
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin gene transcription is enhanced in abnormal wound healing.
Oliver N; Babu M; Diegelmann R
J Invest Dermatol; 1992 Nov; 99(5):579-86. PubMed ID: 1431220
[TBL] [Abstract][Full Text] [Related]
7. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
[TBL] [Abstract][Full Text] [Related]
8. Hexose sugars differentially alter collagen gene expression and synthesis in fibroblasts derived from granulation tissue, hypertrophic scar and keloid.
Kössi J; Vähä-Kreula M; Peltonen J; Risteli J; Laato M
Arch Dermatol Res; 2004 May; 295(12):521-6. PubMed ID: 15045512
[TBL] [Abstract][Full Text] [Related]
9. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW
Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study.
Tanriverdi-Akhisaroglu S; Menderes A; Oktay G
Cell Biochem Funct; 2009 Mar; 27(2):81-7. PubMed ID: 19165813
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
[TBL] [Abstract][Full Text] [Related]
12. Gene expression patterns in isolated keloid fibroblasts.
Satish L; Lyons-Weiler J; Hebda PA; Wells A
Wound Repair Regen; 2006; 14(4):463-70. PubMed ID: 16939575
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation.
Dasu MR; Hawkins HK; Barrow RE; Xue H; Herndon DN
J Pathol; 2004 Apr; 202(4):476-85. PubMed ID: 15095275
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing.
Babu M; Diegelmann R; Oliver N
Mol Cell Biol; 1989 Apr; 9(4):1642-50. PubMed ID: 2524650
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
Sato M
Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study of actin and myosin in the scar tissue].
Zhang Q; Qian YL; Cui L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):32-5. PubMed ID: 12563927
[TBL] [Abstract][Full Text] [Related]
17. Elevated prolidase activity in keloids: correlation with type I collagen turnover.
Duong HS; Zhang QZ; Le AD; Kelly AP; Kamdar R; Messadi DV
Br J Dermatol; 2006 May; 154(5):820-8. PubMed ID: 16634881
[TBL] [Abstract][Full Text] [Related]
18. Modeling aberrant wound healing using tissue-engineered skin constructs and multiphoton microscopy.
Torkian BA; Yeh AT; Engel R; Sun CH; Tromberg BJ; Wong BJ
Arch Facial Plast Surg; 2004; 6(3):180-7. PubMed ID: 15148128
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic scars and keloids: a review and new concept concerning their origin.
Kischer CW; Shetlar MR; Chvapil M
Scan Electron Microsc; 1982; (Pt 4):1699-713. PubMed ID: 7184146
[TBL] [Abstract][Full Text] [Related]
20. [Variations of lipid peroxidation products and copper, zinc-superoxide dismutase in pathological scars].
Li W; Cen Y; Wang H; Chen W; Liu D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):838-41. PubMed ID: 18681286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
